Edition:
India

Genprex Inc (GNPX.OQ)

GNPX.OQ on NASDAQ Stock Exchange Capital Market

7.62USD
16 Jul 2018
Change (% chg)

$-0.01 (-0.13%)
Prev Close
$7.63
Open
$7.65
Day's High
$7.76
Day's Low
$7.62
Volume
1,595
Avg. Vol
--
52-wk High
$19.40
52-wk Low
$3.84

Chart for

About

Genprex, Inc. is a clinical stage gene therapy company. The Company is focused on developing cancer-based upon its novel proprietary technology platform, including its initial product candidate, Oncoprex, immunogene therapy, or Oncoprex. The Company’s Oncoprex is lead product candidate, is the subject of an ongoing Phase I/II... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $--
Shares Outstanding(Mil.): 0.33
Dividend: --
Yield (%): --

Financials

BRIEF-Genprex Announces $10 Million Private Placement

* GENPREX INC - PER SHARE PURCHASE PRICE OF COMMON STOCK IS $12.07, INITIAL EXERCISE PRICE FOR WARRANTS IS $15.62 PER SHARE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

07 May 2018

BRIEF-Genprex Files For Non-Timely 10 K With U.S. SEC

* GENPREX INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text for Eikon: [https://bit.ly/2q36an3] Further company coverage:

04 Apr 2018

Earnings vs. Estimates

No consensus analysis data available.